Endra Inc

Endra Life Sciences Inc. (ENDRA), based in Ann Arbor, Michigan, is a medical device company focused on developing innovative ultrasound technologies. The company employs 25 people and generates approximately $6 million in annual revenue. ENDRA is pioneering the use of Thermo-Acoustic Enhanced UltraSound (TAEUS™) to provide clinicians with advanced visualization capabilities of human tissue composition, function, and temperature. This technology aims to rival the capabilities of CT and MRI scans but at a lower cost and directly at the point-of-care. Their initial application leverages TAEUS to quantify fat in the liver, facilitating early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA's mission is to revolutionize ultrasound technology, expanding access to better healthcare by offering clinicians powerful new diagnostic and monitoring tools. The company recognizes the global burden of NAFLD, a condition affecting over 1 billion people worldwide, and its progression to more severe liver diseases. For more information about ENDRA Life Sciences Inc. and its TAEUS platform, please visit www.endrainc.com.